Billerica, MA – Seahorse Bioscience, Inc., the leader in the design and development of instruments for assessing cellular bioenergetics, has announced Research Instruments Pte Ltd as the distributor of Seahorse XF Analyzers and consumables in South East Asia.

Seahorse XF Extracellular Flux Analyzers provide the first and only kinetic method to measure the two major energy producing pathways – mitochondrial respiration and glycolysis – in living cells in a microplate.

“Research Instruments Pte Ltd. provides end-to-end solutions for all our customers, contributing to the scientific community by facilitating access to important research tools via the introduction of new technology. We believe the Seahorse XF Analyzers will be readily adopted by scientists in the S.E. Asia region,“ said Gregor Kent, Chief Executive Officer, and principal founder of Research Instruments Pte Ltd.

Seahorse XF Analyzers enable scientists to assess the impact of disease, drugs, genetic manipulations, and environmental effects on cells by monitoring the rate that cells consume oxygen and produce metabolic byproducts; which identifies mitochondrial dysfunction and changes in cell metabolism earlier than existing technologies.

“Our initial sales in Singapore are generating interest from pharma in the Biosphere and the academic community, so finding a distributor who provides quality sales, service and support to customers in the cell based assay market was paramount.” noted Steve Chomicz, VP Sales and Marketing for Seahorse. “Research Instruments Pte Ltd, with a great reputation in S. E. Asia, meets our requirements, allowing us to accelerate our sales in Singapore, Malaysia, and Thailand, as they have existing relationships with our ideal customer base.”

About Research Instruments Pte Ltd

Research Instruments Pte Ltd was founded in 1989 and represents leading scientific manufacturers providing current and next-generation tools and technologies together with training, applications support, instrument installation, validation, and maintenance support throughout S.E. Asia. The RI group of companies includes Research Instruments Pte Ltd (Singapore), Research Instruments Sdn Bhd (Malaysia), RI Technologies Ltd (Thailand), and Origen Laboratories Pte Ltd (Singapore).

For more information, please visit www.ri.com.sg

About Seahorse Bioscience

Seahorse XF instruments have become the new standard in cellular bioenergetic measurements. Over 1,500 scientists worldwide are advancing their research in understanding the role of cellular bioenergetics in Neurodegeneration, Aging, Cancer, Cardiovascular, Cell Physiology, Toxicology & Hepatobiology, Immunology, Infectious Diseases, Mitochondrial Diseases, Model Organisms, Obesity, Diabetes, Metabolic Disorders, Screening, and Translational Medicine. Founded in 2001, Seahorse Bioscience is headquartered in Billerica, Massachusetts, U.S., and has regional offices in Copenhagen, Denmark; and Shanghai, China.